Dr. Martin J. Murphy, Founding CEO of the CEO Roundtable on Cancer
Dr. Martin Murphy accepted the challenge from President George H.W. Bush to lead what would become the CEO Roundtable on Cancer as its Founding Chief Executive Officer, a role he held until January 2020. He retired from the CEO Roundtable on Cancer's Board of Directors in 2020 but remains Chief Executive Officer of the CEO Roundtable on Cancer – China.
Dr. Murphy also was the Founding CEO of Project Data Sphere, LLC, a non-profit enterprise devoted to cancer clinical trial data-transparency, data-sharing and data-analysis founded by the CEO Roundtable on Cancer. He retired from its Board of Directors in 2020 also.
Dr. Murphy is a member of the National Cancer Policy Forum of the National Academy of Medicine of the National Academy of Sciences; Director Emeritus of the Foundation for the National Institutes of Health (FNIH). He is a Fellow of the American Society of Clinical Oncology (ASCO), and founding Executive Editor of three peer-reviewed biomedical journals: The Oncologist, Stem Cells and Stem Cells Translational Medicine.
A co-founder of the Society for Translational Oncology; a member of the Scientific Advisory Board of Hatteras Venture Partners; a charter member of the International Advisory Board of the VU University Medical Imaging Center; a charter member of Queen's University Belfast School of Medicine International Review Board; Dr. Murphy is also Chairman Emeritus of the Conquer Cancer Foundation of ASCO; convener of ACT-China; and a steering committee member and senior consultant to the Chinese Society of Clinical Oncology (CSCO).